Huma vs Veeva Systems
Side-by-side comparison of AI visibility scores, market position, and capabilities
Digital health platform with 50M+ patients engaged and 4,500+ hospital deployments; holds FDA 510k clearance for RPM; acquired Aluna (respiratory monitoring) in May 2025 and launched Pfizer hemophilia cloud platform in Jan 2025.
About
Huma (formerly Medopad) is a London-based digital health company that operates a cloud-based remote patient monitoring (RPM) and decentralized clinical trial platform used by hospitals, health systems, pharmaceutical companies, and medical device manufacturers. Founded in 2011, Huma has grown to serve more than 4,500 hospitals and clinics worldwide, engaging over 50 million patients through its digital health platform. The company's FDA Class II 510k-cleared RPM solution combines a patient-facing mobile app with a clinician portal that enables real-time monitoring of vital signs, symptoms, and treatment adherence, reducing unnecessary hospital admissions and enabling earlier clinical intervention.
Veeva Systems (VEEV) reported $2.7B revenue in FY2025, up 14% YoY. #1 cloud platform for life sciences. ~8,000 employees. HQ: Pleasanton, CA. Market cap ~$40B.
About
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executive) and Matt Wallach, Veeva built its platform on Salesforce and later developed its own Vault cloud infrastructure. The company became a public benefit corporation (PBC) in 2021. Veeva reported revenues of $2.7B in fiscal year 2025 (ending January 2025), up 14% year-over-year, with a market capitalization of approximately $40B.
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.